Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
DOCARAVIMAB, MIROMAVIMAB bulk supplier for pharma manufacturers

Docaravimab, Miromavimab 600IU Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 600IU

Reference Brands: TWINRAB

Category: Vaccines

Injection is a combination medication containing docaravimab and miromavimab. It is indicated for post-exposure prophylaxis to prevent rabies infection in people who are exposed to the virus. It is given in combination with the rabies vaccine. Rabies is a viral disease which causes inflammation of the brain. It can spread to pets and people if they are bitten or scratched by a virus carrying animals such as dogs, bats, etc. Even though it is a fatal disease, it is preventable.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

-

Docaravimab, Miromavimab — third party manufacturing & bulk supply

Docaravimab, Miromavimab 600IU is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Docaravimab, Miromavimab is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Docaravimab, Miromavimab listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Docaravimab, Miromavimab →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

DOCARAVIMAB, MIROMAVIMAB is listed as Injection in 600IU. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

DOCARAVIMAB, MIROMAVIMAB is referenced against TWINRAB. Reference brands are shown for identification only and remain the property of their respective trademark owners.

DOCARAVIMAB, MIROMAVIMAB is catalogued under Vaccines on PharmaTradz. Related products within the same category are listed at the foot of this page.

Submit an RFQ stating your destination market, required quantity and whether you need stock supply, third party manufacturing or dossier licensing. Matched suppliers respond with pricing, MOQ and lead times.

Related Products

Respiratory Syncytial Virus Mrna Vaccine

Strength:
0.5 mL

Form: injection (prefilled syringe)

Reference Brands: mRESVIA (USA/EU)

View Details
Inactivated Vaccines

Strength:
Dose and concentration depend on formulations

Form: Injectable suspension (IM administration), Lyophilized powder for reconstitution

Reference Brands: Sinovac Coronavac. Covaxin(EU)

View Details
Viral Vector Vaccines

Strength:
0.5 mL

Form: Intramuscular injectable suspension (IM)

Reference Brands: US: Johnson & Johnson’s Janssen (Jcovden)

View Details
Mrna-Based Vaccines

Strength:
30 µg and 100 µg

Form: Injectable suspension

Reference Brands: Comirnaty, Spikevax(US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.